Data / Form D filings / Magnendo Corp.
Magnendo Corp.: Form D filings
Magnendo Corp., a biotechnology company in Newton, MA, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on July 29, 2026, reports $18 million sold of a $18 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 300 WASHINGTON STREET SUITE 150, Newton, MA, 02458
- Phone
- (617) 852-3504
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2024
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2026763
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jul 29, 2026 | New notice | $18,000,000 | $18,000,000 | 10 | Jul 17, 2026 | sec.gov | |
| Oct 23, 2024 | Amendment | $3,500,000 | $2,254,999 | $1,245,001 | 37 | Jun 5, 2024 | sec.gov |
| Jun 20, 2024 | New notice | $2,500,000 | $1,469,999 | $1,030,001 | 31 | Jun 5, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Yoonho Kim | Executive Officer, Director | |
| Aman Patel | Director | |
| Jeffrey Arnold | Director | |
| Xuanhe Zhao | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jul 27, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Magnendo Corp. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.